» Articles » PMID: 4032400

Phospholipase A2 Activity in Sera and Synovial Fluids in Rheumatoid Arthritis and Osteoarthritis. Its Possible Role As a Proinflammatory Enzyme

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 1985 Apr 1
PMID 4032400
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Phospholipase A2 (PLA2) activity was found in the sera and synovial fluids (SF) in rheumatoid arthritis (RA) and osteoarthritis (OA). PLA2 activity in RA SF was 6158 +/- 549 (SEM) U/ml (n = 48) and in RA sera 554 +/- 175 U/ml (normal sera-115 +/- 12 U/ml). In OA SF PLA2 activity was 5069 +/- 542 U/ml (n = 28), and in OA sera 268 +/- 55 U/ml. There was no significant difference between SF PLA2 activity in RA and OA. PLA2 activity in SF did not correlate with muramidase (lysozyme), beta-glucuronidase, total protein or white cell count, which were all significantly higher in RA SF than OA. A positive correlation between PLA2 in SF and matched sera was found in both RA and OA. It may be concluded that significant elevation of extracellular PLA2 occurs in both RA and OA, especially in the SF. The fact that high PLA2 did not correlate with other enzymes such as lysozyme and beta-glucuronidase, which are usually high in RA and low in OA SF, may mean that the handling of PLA2 in the joint space is different from other enzymes.

Citing Articles

Targeting TRPC channels for control of arthritis-induced bone erosion.

Ray S, McCall J, Tian J, Jeon J, Douglas A, Tyler K Sci Adv. 2025; 11(3):eabm9843.

PMID: 39813349 PMC: 11734723. DOI: 10.1126/sciadv.abm9843.


5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis.

Kim J, Ryu G, Seo J, Go M, Kim G, Yi S Nat Commun. 2024; 15(1):1024.

PMID: 38310093 PMC: 10838344. DOI: 10.1038/s41467-024-45174-6.


PLA-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy.

Markovic M, Ben-Shabat S, Nagendra Manda J, Abramov-Harpaz K, Regev C, Miller Y Pharmaceutics. 2022; 14(3).

PMID: 35336048 PMC: 8950246. DOI: 10.3390/pharmaceutics14030675.


Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA-Mediated Activation.

Markovic M, Abramov-Harpaz K, Regev C, Ben-Shabat S, Aponick A, Zimmermann E Int J Mol Sci. 2022; 23(5).

PMID: 35269813 PMC: 8910962. DOI: 10.3390/ijms23052673.


The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation.

Dore E, Joly-Beauparlant C, Morozumi S, Mathieu A, Levesque T, Allaeys I JCI Insight. 2022; 7(2).

PMID: 35076027 PMC: 8855825. DOI: 10.1172/jci.insight.152638.